| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |